These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 147599

  • 1. Adverse reactions to neuroleptic drugs.
    Vanĕcek J, Vinar O, Fink Z.
    Act Nerv Super (Praha); 1978 Feb; 20(1):50-1. PubMed ID: 147599
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa.
    Kazamatsuri H, Cole JO.
    Arch Gen Psychiatry; 1972 Dec; 27(6):824-7. PubMed ID: 4637899
    [No Abstract] [Full Text] [Related]

  • 3. [Adverse effects in the treatment with neuroleptics].
    Malá E.
    Cesk Pediatr; 1976 May; 31(5):270-2. PubMed ID: 132306
    [No Abstract] [Full Text] [Related]

  • 4. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R, Gagnon MA, Gauthier R, Jéquier JC.
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Neuroleptic manifestations in daily practice].
    Stojanović T, Savić B, Todorović M.
    Med Pregl; 1978 Jun; 31(1-2):63-5. PubMed ID: 651834
    [No Abstract] [Full Text] [Related]

  • 7. The neuroleptics. 4. Toxicity and side effects in man and in the laboratory animal.
    Degkwitz R, Heushgem C, Hollister LE, Jacob J, Julou L, Lambert PA, Marsboom R, Meier-Ruge W, Schaper WK, Tuchmann-Duplessis HC.
    Mod Probl Pharmacopsychiatry; 1970 Jun; 5():71-84. PubMed ID: 5527173
    [No Abstract] [Full Text] [Related]

  • 8. [Dosage and adverse effects of psychopharmacological agents].
    Flegel H.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):327-33. PubMed ID: 4260335
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical implications of dopaminergic and cholinergic effects of neuroleptic drugs.
    Stimmel GL.
    Hosp Pharm; 1976 Feb; 11(2):50-1, 54-6. PubMed ID: 10235740
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The depot neuroleptic agent fluspirilene (author's transl)].
    Angst J, Frei M, Scharfetter Chr.
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early detection of bone-marrow injury due to drugs.
    Conn Med; 1969 Nov; 33(11):693. PubMed ID: 5369512
    [No Abstract] [Full Text] [Related]

  • 20. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P, Robotti E, Nardini M.
    Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.